Inhibition of amyloid fibril formation of β-amyloid peptides via the amphiphilic surfactants

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 3, 2005, Pages 307-313

  Wang, Steven S S ^a   Chen, Ya Ting ^a   Chou, Shang Wei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

amyloid; Aggregation; Alzheimer's disease; Fibril; Inhibitor

Indexed keywords

1,2 DIHEPTANOYLGLYCERO 3 PHOSPHOCHOLINE; 1,2 DIHEXANOYLGLYCERO 3 PHOSPHOCHOLINE; AMPHOPHILE; AMYLOID BETA PROTEIN[1-40]; CONGO RED; SURFACTANT; THIOFLAVINE; UNCLASSIFIED DRUG;

ALKALINITY; ALZHEIMER DISEASE; ARTICLE; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; DRUG EFFECT; FLUORESCENCE ANALYSIS; INCUBATION TIME; PH; PHYSIOLOGY; PRIORITY JOURNAL; TURBIDITY;

AMYLOID BETA-PROTEIN; CIRCULAR DICHROISM; CONGO RED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; NEPHELOMETRY AND TURBIDIMETRY; PEPTIDE FRAGMENTS; PHOSPHATIDYLCHOLINES; SURFACE-ACTIVE AGENTS;

EID: 25144471718     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.05.004     Document Type: Article

References (42)

1. R. Mayeux, and M. Sano Treatment of Alzheimer's disease N. Engl. J. Med. 341 1999 1670 1679
2. D.S. Geldmacher, and P.J. Whitehouse Evaluation of dementia N. Engl. J. Med. 335 1996 330 336
3. D.J. Selkoe Alzheimer's disease: A central role for amyloid J. Neuropathol. Exp. Neurol. 53 1994 438 447
4. D.J. Selkoe Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease Trends Neurosci. 16 1993 403 409
5. J. Busciglio, J. Yeh, and B.A. Yankner Beta-amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins J. Neurochem. 61 1993 1565 1568
6. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.J. Selkoe Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
7. D.R. Howlett, K.H. Jennings, D.C. Lee, M.S. Clark, F. Brown, R. Wetzel, S.J. Wood, P. Camilleri, and G.W. Roberts Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide Neurodegeneration 4 1995 23 32
8. B. Seilheimer, B. Bohrmann, L. Bondolfi, F. Muller, D. Stuber, and H. Dobeli The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology J. Struct. Biol. 119 1997 59 71
9. R.V. Ward, K.H. Jennings, R. Jepras, W. Neville, D.E. Owen, J. Hawkins, G. Christie, J.B. Davis, A. George, E.H. Karran, and D.R. Howlett Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide Biochem. J. 348 Pt 1 2000 137 144
10. F.G. Defelice, and S.T. Ferreira Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease An. Acad. Bras. Cienc. 74 2002 265 284
11. K. Ono, K. Hasegawa, M. Yamada, and H. Naiki Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro Biol. Psychiatry 52 2002 880 886
12. K. Ono, K. Hasegawa, Y. Yoshiike, A. Takashima, M. Yamada, and H. Naiki Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro J. Neurochem. 81 2002 434 440
13. K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki, and M. Yamada Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease J. Neurochem. 87 2003 172 181
14. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J. Neurosci. Res. 75 2004 742 750
15. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro Biochim. Biophys. Acta 1690 2004 193 202
16. H. Naiki, K. Hasegawa, I. Yamaguchi, H. Nakamura, F. Gejyo, and K. Nakakuki Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro Biochemistry 37 1998 17882 17889
17. F.G. De Felice, M.N. Vieira, L.M. Saraiva, J.D. Figueroa-Villar, J. Garcia-Abreu, R. Liu, L. Chang, W.L. Klein, and S.T. Ferreira Targeting the neurotoxic species in Alzheimer's disease: Inhibitors of Abeta oligomerization FASEB J. 18 2004 1366 1372
18. M. Pappolla, P. Bozner, C. Soto, H. Shao, N.K. Robakis, M. Zagorski, B. Frangione, and J. Ghiso Inhibition of Alzheimer beta-fibrillogenesis by melatonin J. Biol. Chem. 273 1998 7185 7188
19. T. Thomas, T.G. Nadackal, and K. Thomas Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation NeuroReport 12 2001 3263 3267
20. S. Lee, K. Carson, A. Rice-Ficht, and T. Good Hsp20, a novel {alpha}-crystallin, prevents A{beta} fibril formation and toxicity Protein Sci. 14 2005 593 601
21. A. Lomakin, D.S. Chung, G.B. Benedek, D.A. Kirschner, and D.B. Teplow On the nucleation and growth of amyloid beta-protein fibrils: Detection of nuclei and quantitation of rate constants Proc. Natl. Acad. Sci. U. S. A. 93 1996 1125 1129
22. S.J. Lin, Y.J. Shiao, C.W. Chi, and L.M. Yang Abeta aggregation inhibitors: Part 1. Synthesis and biological activity of phenylazo benzenesulfonamides Bioorg. Med. Chem. Lett. 14 2004 1173 1176
23. K.J. Marcinowski, H. Shao, E.L. Clancy, and M.G. Zagorski Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles J. Am. Chem. Soc. 120 1998 11082 11091
24. W.E. Klunk, J.W. Pettegrew, and D.J. Abraham Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation J. Histochem. Cytochem. 37 1989 1273 1281
25. N. Sreerama, and R.W. Woody Computation and analysis of protein circular dichroism spectra Methods Enzymol. 383 2004 318 351
26. N. Sreerama, and R.W. Woody Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set Anal. Biochem. 287 2000 252 260
27. H. LeVine III Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
28. J.W. Kelly Alternative conformations of amyloidogenic proteins govern their behavior Curr. Opin. Struct. Biol. 6 1996 11 17
29. J.W. Kelly The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr. Opin. Struct. Biol. 8 1998 101 106
30. P.T. Lansbury Jr. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease Proc. Natl. Acad. Sci. U. S. A. 96 1999 3342 3344
31. J.D. Sipe Amyloidosis Annu. Rev. Biochem. 61 1992 947 975
32. J.D. Sipe Amyloidosis Crit. Rev. Clin. Lab. Sci. 31 1994 325 354
33. C.J. Pike, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures Eur. J. Pharmacol. 207 1991 367 368
34. Y. Kiuchi, Y. Isobe, and K. Fukushima Type IV collagen prevents amyloid beta-protein fibril formation Life Sci. 70 2002 1555 1564
35. Y. Kiuchi, Y. Isobe, K. Fukushima, and M. Kimura Disassembly of amyloid beta-protein fibril by basement membrane components Life Sci. 70 2002 2421 2431
36. S.J. Wood, L. MacKenzie, B. Maleeff, M.R. Hurle, and R. Wetzel Selective inhibition of Abeta fibril formation J. Biol. Chem. 271 1996 4086 4092
37. M.M. Pallitto, J. Ghanta, P. Heinzelman, L.L. Kiessling, and R.M. Murphy Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity Biochemistry 38 1999 3570 3578
38. C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy Nat. Med. 4 1998 822 826
39. C. Hetenyi, Z. Szabo, E. Klement, Z. Datki, T. Kortvelyesi, M. Zarandi, and B. Penke Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease Biochem. Biophys. Res. Commun. 292 2002 931 936
40. D.A. Kirschner, C. Abraham, and D.J. Selkoe X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation Proc. Natl. Acad. Sci. U. S. A. 83 1986 503 507
41. C. Nordstedt, J. Naslund, L.O. Tjernberg, A.R. Karlstrom, J. Thyberg, and L. Terenius The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils J. Biol. Chem. 269 1994 30773 30776
42. K. Halverson, P.E. Fraser, D.A. Kirschner, and P.T. Lansbury Jr. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic beta-protein fragments Biochemistry 29 1990 2639 2644